Department of Discovery Immunology, Genentech, South San Francisco, California, USA.
Institute for Systems and Genomics Biology and Department of Human Genetics, The University of Chicago, Chicago, Illinois, USA.
Nat Immunol. 2014 Feb;15(2):161-7. doi: 10.1038/ni.2795. Epub 2013 Dec 22.
CD11b(+) dendritic cells (DCs) seem to be specialized for presenting antigens via major histocompatibility (MHC) class II complexes to stimulate helper T cells, but the genetic and regulatory basis for this is not established. Conditional deletion of Irf4 resulted in loss of CD11b(+) DCs, impaired formation of peptide-MHC class II complexes and defective priming of helper T cells but not of cytotoxic T lymphocyte (CTL) responses. Gene expression and chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) analyses delineated an IRF4-dependent regulatory module that programs enhanced MHC class II antigen presentation. Expression of the transcription factor IRF4 but not of IRF8 restored the ability of IRF4-deficient DCs to efficiently process and present antigen to MHC class II-restricted T cells and promote helper T cell responses. We propose that the evolutionary divergence of IRF4 and IRF8 facilitated the specialization of DC subsets for distinct modes of antigen presentation and priming of helper T cell versus CTL responses.
CD11b(+)树突状细胞 (DC) 似乎专门通过主要组织相容性 (MHC) Ⅱ类复合物来呈递抗原,以刺激辅助性 T 细胞,但这种作用的遗传和调控基础尚未确定。Irf4 的条件性缺失导致 CD11b(+) DC 的缺失、肽-MHC Ⅱ类复合物形成受损以及辅助性 T 细胞而非细胞毒性 T 淋巴细胞 (CTL) 应答的初始缺陷。基因表达和染色质免疫沉淀 followed by deep sequencing (ChIP-Seq) 分析描绘了一个依赖于 IRF4 的调控模块,该模块编程增强了 MHC Ⅱ类抗原呈递。转录因子 IRF4 的表达但不是 IRF8 的表达恢复了 IRF4 缺陷型 DC 有效处理和呈递抗原给 MHC Ⅱ类限制性 T 细胞并促进辅助性 T 细胞应答的能力。我们提出,IRF4 和 IRF8 的进化分歧促进了 DC 亚群在抗原呈递和辅助性 T 细胞与 CTL 应答的初始方面的特定模式的专业化。